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Based on new methods of plasma cell assessment, the prevalence of chronic endometritis in 46 
women with various categories of reproductive failure may have been over-estimated in 47 
earlier studies.  48 
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ABSTRACT 49 
Objective: To compare the prevalence of chronic endometritis (CE) when different 50 
diagnostic methods are used. 51 
Design: Prospective observational study. 52 
Setting: University affiliated hospital. 53 
Patient(s): Four groups of women were studied, including women with proven fertility 54 
(Fertile, n=40), unexplained recurrent miscarriage (RM, n=93), recurrent implantation failure 55 
(RIF, n=39) and infertile subjects undergoing endometrial scratch in a natural cycle preceding 56 
frozen-thawed embryo transfer (Infertility, n=48). 57 
Intervention(s): Endometrial biopsy was performed precisely seven days following LH 58 
surge (LH+7). Plasma cells were identified by traditional H&E staining and 59 
immunohistochemistry (IHC) for Syndecan-1(CD138).  60 
Main Outcome Measure(s): The prevalence of chronic endometritis. 61 
Result(s): The use of CD138 epitope is more sensitive than H&E staining in identifying 62 
plasma cells. The use of plasma cell count per unit area had the lowest observer variability 63 
than that of cell count per 10 randomly chosen HPF or cell count per section. Using this 64 
method, the prevalence of CE in women with RM, RIF and Infertility were 10.8%, 7.7%, and 65 
10.4%, respectively, not significantly higher than that of fertile subjects (5.0%). 66 
Conclusion(s): Using what may be a new method of plasma cell assessment, it appears that 67 
the prevalence rates of CE reported in many earlier studies may have been over-estimated. 68 
Chinese Clinical Trials Registry Number: ChiCTR-IOC-16007882 69 
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Text 72 
INTRODUCTION 73 
Chronic endometritis (CE) refers to local persistent inflammation of the endometrium. CE 74 
has been reported to be associated with various subgroups of reproductive failure, including 75 
infertility (1-3), recurrent miscarriage (4-8), or recurrent implantation failure (4, 9-11). 76 
The presence of plasma cells in endometrial stroma has been accepted as the gold standard 77 
method to establish a diagnosis of CE (12). Nevertheless, the reported prevalence of CE in 78 
endometrial biopsy specimens varied considerably, ranging from 3 to 60% (Table 1). There 79 
are several possible explanations to account for the wide variation reported. Firstly, there are 80 
two different methods used to identify plasma cells. Traditionally, plasma cells are identified 81 
in H&E stained specimens. However, the identification of plasma cells in H&E sections 82 
requires experience coupled with diligent search, without which they can be easily missed. A 83 
more recently introduced method is immunohistochemistry (IHC) staining for Syndecan-1 84 
(CD138), a proteoglycan found on the cell surface of plasma cells and keratinocytes. This has 85 
been found to improve the sensitivity and accuracy for identifying plasma cells, essential for 86 
the diagnosis of CE (13-15).  87 
Secondly, various investigators have used different approaches to quantify CD138+ cell 88 
count (Table 1). In the first approach, the number of plasma cell per whole section was 89 
measured. In the second approach, the plasma cell count per a defined number of randomly 90 
chosen high power field (HPF, say 10) was measured. There are rationales behind each of 91 
these two approaches. Some investigators advocated scrutinizing the entire specimen as they 92 
believed that plasma cells are not normally present in the endometrium and the finding of one 93 
or more plasma cells is indicative of a diagnosis of CE (12, 16, 17). One shortcoming of such 94 
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an approach is that it does not take into account the size of the specimen. One would expect 95 
that, other things being equal, the larger is the specimen size, the more likely it is to find 96 
plasma cells, and vice versa. Consequently, other authors introduced the concept of plasma 97 
cell density to correct for the size of the specimen examined; they advocated examining 10 or 98 
more chosen HPFs and expressed the number of plasma cell detected per HPF or per 10 HPF, 99 
as each HPF is equivalent to a defined area (4, 6, 10, 11, 15, 18, 19). To avoid bias in 100 
selecting the HPFs to be examined and to improve objectivity, it is desirable to have 101 
randomly chosen fields. However, the potential disadvantage of such an approach is that 102 
plasma cells are usually present in low numbers and so the inclusion of only 10 selected 103 
HPFs may not be sufficient to produce a consistently reproducible result. We postulate that a 104 
new method of plasma cell assessment which combines the positive attributes of the two 105 
above-mentioned methods would be to count all CD138+ cells in the entire section, then 106 
measure the area of the examined tissue section and express the result as plasma cell count 107 
per unit area. In this way, it would overcome the problem of local fluctuation of plasma cell 108 
count as well as correcting for the variation in results due to sample size difference.  109 
There is also no consensus on the diagnostic criteria used to define what constitutes CE.  At 110 
least seven criteria have been reported in the literature, which included ≥1 plasma cell/section 111 
(20), ≥1 plasma cell/HPF (10), ≥1 plasma cell/10 HPF (3), ≥5 plasma cells /10 HPF (4), ≥5 112 
plasma cells/20 HPF (22), and the presence of 1-5 plasma cells/HPF or discrete clusters <20 113 
plasma cells (7), ≥0.25 endometrial stromal plasmacyte density index (ESPDI, the sum of the 114 
stromal CD138+ cell counts divided by the number of the HPFs evaluated) (11) (see Table 1). 115 
The proposed criteria all appeared rather arbitrarily chosen, not based on reference ranges 116 
derived from normal fertile populations.  117 
In this study, our aim was to establish a reference range of plasma cell count in the 118 
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endometrium of fertile subjects by using two different methods of identification and three 119 
different methods of quantification, as discussed above, followed by a comparison of the 120 
performance of these methods. The prevalence rates of CE so derived among women with 121 
reproductive failure was then determined, using this methodology, with a view to 122 
determining the optimal strategy to identify and quantify plasma cell and to diagnose CE.   123 
MATERIALS AND METHODS 124 
Participants 125 
Subjects were recruited from women attending the Department of Obstetrics and Gynecology, 126 
Prince of Wales Hospital, The Chinese University of Hong Kong. Women were recruited 127 
from four groups: (1) fertile control group: healthy women with at least one live birth  within 128 
2 years (n=40); (2) unexplained RM group: women with recurrent miscarriage, which was 129 
defined as the loss of three or more consecutive pregnancies before 24 weeks gestation (23) 130 
(n=93); (3) RIF group: women with recurrent implantation failure which was defined as 131 
failure to achieve a clinical pregnancy after transfer of at least four good quality embryos in 132 
three or more transfer cycles in women under the age of 40 years (24) (n=39); and (4) 133 
infertile group: women with infertility undergoing endometrial scratch in a natural cycle 134 
preceding frozen-thawed embryo transfer using non donor oocytes (n=48).  135 
The inclusion criteria were women who were between 20 to 40 years of age with regular 136 
menstrual cycle (25-35 days), normal pelvic ultrasonography, and had not used any 137 
antibiotics, oestrogen or progestogen hormonal therapy, steroid treatment or intrauterine 138 
contraceptive device within 2 months of recruitment. The exclusion criteria included the 139 
presence of hydrosalpinx, structural uterine abnormalities, parental chromosomal 140 
abnormalities and significant medical conditions such as systemic lupus erythematosus.  141 
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Endometrial Biopsy  142 
All subjects in this study had daily urine dipstick test from day 9 of the menstrual cycle 143 
onwards to identify the LH surge (ovulation), which was used to precisely time the 144 
endometrial biopsies to seven days after the LH surge (day LH+7). All biopsies were 145 
obtained using a Pipelle sampler (Prodimed, France) or Pipet Curettage (Cooper Surgical, 146 
USA). The specimens were immediately placed into 10% neutral buffered formalin for over-147 
night fixation at room temperature and then embedded into paraffin wax. 148 
Processing of Specimen  149 
The paraffin-embedded human endometrial tissues were cut into sections (4 m) and then 150 
dewaxed in xylene and then rehydrated through descending ethanol to phosphate-buffered 151 
saline.  152 
Haematoxylin-Eosin (H&E) staining. Paraffin-embedded human endometrial tissue sections 153 
were examined with routine H&E staining.  154 
Immunohistochemistry (IHC) staining. Slides were pre-treated with microwave heating for 20 155 
minutes in sodium citrate buffer for antigen retrieval, and then quenched with 0.3%v/v 156 
hydrogen peroxidase in methanol to block endogenous peroxidase activity. Then the sections 157 
were blocked with rabbit serum to prevent non-specific binding and then incubated with a 158 
1:50 dilution of mouse monoclonal antibody against human Syndecan-1 (clone B-A38; Cell 159 
Marque, Rocklin, CA, USA) overnight at 4°C. After incubation, the sections were washed in 160 
phosphate-buffered saline Tween 20 and incubated with secondary rabbit anti-mouse 161 
horseradish peroxidase (HRP) labelled antibody (1:100, ab97046, Abcam, Cambridge, MA, 162 
USA) for one hour, followed by colour development with 3, 3-diaminobenzidine (DAB; 163 
DAKO, CA, USA), counterstained with haematoxylin, dehydrated with ethanol, cleared in 164 
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xylene and mounted with a cover slide. 165 
Image Acquisition and Analysis 166 
Image analysis was performed by one operator who firstly scanned the slides at lower 167 
magnification, and then captured images (400) of all the fields of CD138+ plasma cells 168 
using the Leica DM6000B system (Leica Microsystems Ltd., Wetzlar, Germany). Then the 169 
whole section of each sample was tile scanned under 50 magnifications by the same system, 170 
which was able to merge separate images into one image covering all the tissue. Cell counts 171 
and section area were analysed using Image J (Version 1.51a, Wayne Rasband, NIH, USA). 172 
The total number of plasma cells was determined by counting immune-positive cells in the 173 
entire specimen. Cells were considered to be likely CD138+ plasma cells, if they exhibited 174 
unambiguous complete brown staining with intact cell membrane, a clearly defined nucleus 175 
typical of a plasma cell, and occurring singly or as small clusters of cells, excluding 176 
background stroma, glands and other confounders. The identification and counting of the 177 
CD138+ cells was performed manually under the microscope, whereas the measurement of 178 
the specimen area was made on images captured in the computer by Image software entirely. 179 
Determination of Observer Variability 180 
The intra-observer variability of CD138+ cell count was determined by asking a single 181 
observer to repeat the measurement of 20 randomly chosen specimens on two separate 182 
occasions, without knowledge of the results of the first count. The observer utilised three 183 
different quantification methods to do the measurement, namely method I: CD138+ cell 184 
count per 10 randomly chosen HPF; method II: CD138+ cell count per whole section; 185 
method III: CD138+ cell count per unit area (cell density). For the third method, Image J 186 
software was used to measure the area of the tissue section. 187 
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The inter-observer variability was determined by asking two observers (Y.L. and X.C.) to 188 
perform the measurement of CD138+ cell count on the same set of 20 randomly chosen 189 
specimens, independently of each other, also using the three different quantification methods 190 
as in the case of intra-observer variability study.  191 
Reference Range  192 
In this study, the reference range of plasma cell count or density was derived from the 40 193 
fertile control subjects. Values below the 95th percentile were considered as normal, whereas 194 
values above the 95th percentile were considered as abnormal and indicative of a diagnosis of 195 
CE. 196 
Definition of CE 197 
Chronic endometritis was defined as the presence of CD138+ plasma cell count or density 198 
above the established reference ranges (95th percentile), whatever the quantification method 199 
was used. 200 
Ethical Considerations 201 
This study was approved by the local hospital ethics committee (CREC Ref. No.: 2015.477). 202 
Written informed consents were obtained from all participants.  203 
Statistical Analysis 204 
We have previously analysed the distribution of our data and confirm that results in the 205 
control population was not normally distributed which was the reason why we adopted non-206 
parametric method to analyse the data and used 95
th
 centile as the cut-off instead of 2SD 207 
above the mean (parametric method) as the cut-off. The maternal age and body mass index 208 
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(BMI) of the women in the four groups were compared by ANOVA analysis. Intra- and inter-209 
class correlation coefficients (intra- and inter-CC) with 95% confidence interval (95% CI) 210 
were used to assess the intra- and inter-observer agreement in the calculation of plasma cell 211 
count, area of tissue examined and plasma cell density (intra- and inter- CC values <0.40 212 
were considered as poor agreement, between 0.40 and 0.75 as moderate, and >0.75 as 213 
excellent agreement). Chi-Square test was used to compare the prevalence of CE between 214 
subgroups. Statistical analysis was performed by using SPSS version 23.0 (SPSS Inc., 215 
Chicago, IL, USA) and P value with <0.05 was considered as a statistical significance.   216 
RESULTS 217 
From December 2014 to June 2017, 229 subjects underwent endometrial biopsy. Nine 218 
subjects were excluded because of insufficient tissue obtained. In total, 220 subjects were 219 
included in the study.  220 
Demographics 221 
The demographic details of the subjects are summarized in Supplementary Table 1. The 222 
mean age of all the subjects was 34.4 (range from 21 to 40) years. The mean age in 223 
reproductive failure group (35.4  3.1 years) was significantly (P<0.01) higher than that of 224 
control group (29.6  3.4 years), whilst there was no significant difference between RM, RIF 225 
and Infertility subgroups. There was also no significant difference in body mass index 226 
between groups.  227 
Identification of Plasma Cell 228 
No classical plasma cells were identified in any of the routing H&E stained sections (n=220) 229 
examined in this study while the use of CD138 IHC staining identified presence of one or 230 
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more plasma cells in 95/220 (43.2%) of the specimens examined (Figure 1). In most cases, 231 
the distribution of plasma cells within the endometrium was not uniform, being localized 232 
focally or widely dispersed in the stroma. 233 
Intra-observer Variability of Quantification Methods  234 
The results of the intra-observer variability of the three different quantification methods of 235 
measurement, namely method I: CD138+ cell count per 10 randomly chosen HPF; method II: 236 
CD138+ cell count per whole section; method III: CD138+ cell count per unit area (cell 237 
density) are compared in Supplementary Table 2. The intra-class correlation coefficient 238 
(intra-CC) value of cell count per 10 randomly chosen HPF was 0.46, which was considered 239 
as moderate. The intra-CC of cell count per whole section and cell count per unit area of 240 
whole section were 0.90 and 0.84, respectively, both considered as excellent.  241 
Inter-observer Variability of Quantification Methods 242 
The results of the inter-observer variability of the three different methods of measurement are 243 
compared in Supplementary Table 3. The intra-CC of plasma cell count per 10 randomly 244 
chosen HPF was 0.39, which was considered as poor. The intra-CC of cell count per whole 245 
section and cell count per unit area of whole section were 0.88 and 0.83, respectively, both 246 
considered as excellent. 247 
Reference Range  248 
 In establishing the reference range of the plasma cell count or density, the specimens from 249 
fertile control subjects were examined and the 95
th
 percentile of the results was used to define 250 
the upper limit of the reference range. The reference range for three different methods of 251 
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quantification were: (I) 1.95 CD138+ cells per 10 randomly chosen HPF; (II) 2.95 CD138+ 252 
cells per section; and (III) 5.15 CD138+ cells per 0.1mm
2
 (Table 2). 253 
Prevalence of CE  254 
The prevalence of CE in the various subgroups in this study as determined by the three 255 
different methods of CD138+ cell quantification, in conjunction with two different diagnostic 256 
criteria selected (one based on a previously literature report and the other based on reference 257 
range derived from fertile women) was analysed and compared in Table 2. Quantification 258 
using method I and method II consistently produced higher prevalence rates than 259 
quantification using method III. The application of previously published criteria consistently 260 
produced higher prevalence rates than those produced by the application of criteria based on 261 
reference range derived from fertile population. The prevalence of CE in women with 262 
reproductive failure as determined by quantification methods I or II, regardless of the 263 
diagnostic criteria used, was significantly higher than fertile subjects in three out of the four 264 
chosen criteria used (Table 2). However, the prevalence of CE in women with reproductive 265 
failure and its subgroups, determined by using quantification method III and diagnostic 266 
criteria based on established reference range, was not significantly (p>0.05) higher than that 267 
of fertile subjects.  268 
Confounding Variable 269 
The possible impact of age as a confounding on the results of the expression of CD138 was 270 
examined with the use of regression analysis. There was no significant association between 271 
CD138+ cell density and age. 272 
DISCUSSION 273 
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In this prospective observational study, we have used different methods to identify and 274 
quantify plasma cell count and apply different criteria to diagnose CE; using our proposed 275 
new methods of plasma cell assessment, we found that the prevalence rates of CE reported in 276 
in earlier studies of women with reproductive failure may  have been over-estimated.    277 
Identification of Plasma Cells 278 
The identification of plasma cells in endometrial biopsy specimen continues to be considered 279 
as the gold standard method for the diagnosis of CE (12, 13, 25). Typical plasma cells have a 280 
large cell body, high nuclei/cytoplasm ratio, basophilic cytoplasm, and nuclei with 281 
heterochromatin in a unique arrangement called “spoke-wheel” or “clock-face” pattern (13, 282 
17). However, plasma cells may from time to time be missed in routine histological 283 
examination. The results from this study agree with earlier reports (1, 13-15) on the 284 
usefulness of CD138 immunostaining in the identification of plasma cells, which has been 285 
shown to be a more sensitive and accurate method to identify plasma cells compared with the 286 
conventional H&E staining method (13-15). In accordance with previous publications, we 287 
could not find any classic plasma cells in any of the H&E stained specimens, whilst the use 288 
of CD138 staining led to the detection of one or more plasma cells in 46.1% (83/180) of 289 
samples from women with reproductive failure, and 95/220 (43.2%) for all the subjects in 290 
this study. 291 
Quantification of Plasma Cell 292 
In this study, we have based the diagnosis of CE on the stromal plasma cell count only; there 293 
are a number of morphological features which have been reported to be associated with 294 
chronic endometritis, namely superficial stroma edema, stromal inflammatory infiltrate, 295 
increased stromal density, focal stromal haemorrhage and spindling of stroma, most notably 296 
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in the upper half of the mucosa (12). Greenwood & Morgan (12) argued for the inclusion of  297 
these additional morphologic features in the definition of chronic endometritis, which was 298 
supported by Bayer-Garner and Korourian (13), and Cicinelli et al. (32), but some 299 
investigators based the diagnosis on plasma cell count only (19, 27). We have not included 300 
the additional morphological features proposed by Greenwood & Morgan in our analysis 301 
partly because there is as yet no consensus on the diagnostic value of these features nor are 302 
they easily quantifiable.  303 
It should be noted that the proposed “plasma cell density” measurement in this study referred 304 
to plasma cell count per unit area, calculated from the entire area of the specimen, consisting 305 
of all fields whether complete or not, which is different from the endometrial stromal 306 
plasmacyte density index (ESPDI) which was calculated as the sum of the stromal CD138+ 307 
cell counts divided by the number of the high power fields evaluated (11),  which is in 308 
essence plasma count per selected number of complete HPFs. 309 
Observer Variability  310 
Observer variability is a measure of how reproducible the results are. In this study we directly 311 
compare the observer variability of three different quantification methods and found that the 312 
coefficient of variation of results obtained from the cell count per HPF method was 313 
considerably higher than that of the cell count per section method and the cell density method. 314 
It is likely that the source of variation of the cell count per HPF method comes from the 315 
random nature of selection of the HPF, primarily because the (plasma) cell count is low. 316 
Missing one or two positively stained cells could make a significant difference to the results. 317 
The other two methods, both had intra-observer and inter-observer coefficient of correlation 318 
in the excellent category. The intra and inter-observer variability for cell density appeared 319 
slighter higher than that of cell count per section, which is to be expected, as the 320 
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measurement of cell density requires an additional measurement of area and so introduces an 321 
additional source of variation.   322 
Reference Range 323 
In this study we have chosen to establish the normal ranges derived from a fertile population 324 
and define results above the 95
th
 centile as abnormal (basis for the diagnosis of chronic 325 
endometritis). This approach is commonly used for establishing clinical laboratory values. 326 
The sample size of 40 in the control group is somewhat small and may well be a limitation of 327 
our study. On the other hand, a particularly strength of our study is the special efforts made to 328 
ensure the homogeneity of the specimens (including control group) by collecting them 329 
precisely on day LH+7, which would have reduced the variance of results. 330 
Our finding agrees with that of Achilles and co-workers (26) who found plasma cells were 331 
commonly present in the endometrium of asymptomatic, fertile and healthy women and their 332 
presence alone, in small numbers, may not signify upper genital tract inflammation. Together, 333 
these studies suggest that the hitherto held view that the finding of one or more plasma cell in 334 
the endometrium is abnormal and diagnostic of CE may lead to over diagnosis of the 335 
condition. Some previous studies used hysterectomy specimen as control (21, 22) which 336 
called into question their validity as many of these subjects could well have uterine pathology. 337 
Prevalence of CE in Women with Reproductive Failure 338 
Using the reference range established and based on the CD138+ cell density quantification 339 
method, the prevalence of CE in each of the three subgroups of women with reproductive 340 
failure (10.8% for women with recurrent miscarriage, 7.7% in women with RIF and 10.4% in 341 
women with infertility) was not significantly different from that of the fertile group. In 342 
addition, the prevalence of CE among the entire group of reproductive failure (18/180, 10.0%) 343 
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was also not significantly different from the fertile group. This finding agrees with the earlier 344 
reports of Kasius et al. (27, 28) who observed in a randomized controlled trial that the 345 
prevalence of CE in a population of symptomatic infertile patients was low (2.8%) and that 346 
the contribution of CE to reproductive failure could have been over-estimated in earlier 347 
studies. Further analysis of data in Table 2 showed that the use of cell count per randomly 348 
chosen HPF quantification method or the cell count per section quantification methods both 349 
resulted in over-estimation of prevalence rates. Moreover, the application of arbitrarily 350 
chosen diagnostic criteria used in the literature also led to over-estimation of the prevalence 351 
rates. Our observation provided an explanation for the rather high prevalence rates (up to 352 
60%) of CE reported in earlier studies (Table 1).  353 
Precise Timing of Specimen 354 
A notable feature of our study was that we obtained all our specimens on a precise 355 
chronological date, that is exactly 7 days after the LH surge. Whilst is considered acceptable 356 
to have specimens collected on LH+7 +/- day, we have preferred to include only samples on 357 
a precise chronological date to reduce possible variance in results due to cyclic changes in the 358 
cell count. Several studies suggested that the prevalence of CE appeared to be higher when 359 
the biopsy was obtained in the proliferative phase than the secretory phase (29-31). It remains 360 
possible that timing of the biopsy in different stages of the cycle could be a confounding 361 
variable.  362 
Other Diagnostic Method       363 
In addition to the identification of plasma cell in endometrial biopsy specimen, hysteroscopy 364 
has been proposed as an alternative method of diagnosis for CE (32-34). Although 365 
hysteroscopy has an accuracy rate of 92.7% in the diagnosis of CE (35), histological 366 
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identification of plasma cell remains the gold standard of diagnosis of CE (12, 16, 17). 367 
Although it is believed that CE is due to an underlying infection, routine microbial culture of 368 
endometrial secretion in women with CE is often negative and so precludes its use in clinical 369 
diagnosis (36). However, it is now possible to examine the entire microflora present in the 370 
endometrium by genomic testing (microbiome study). A recent study by Moreno and co-371 
workers (37) demonstrated the existence of an endometrial microbiota that is highly stable 372 
around the time of implantation and changes in microbiota profile appeared to be associated 373 
with adverse reproductive outcomes. This finding adds a novel microbiological dimension to 374 
our understanding of CE. It would be of interest to establish what specific changes in 375 
microbiome induce the emergence of plasma cells in the endometrium.   376 
Consensus and Clinical Significance  377 
A review of the literature on the prevalence of CE, revealed that many investigators used 378 
different methods of quantification and applied different diagnostic criteria (see Table 1), 379 
often without justification. There was a lack of consensus in the diagnostic approach to define 380 
CE. In order to make progress in the field and to provide effective and appropriate treatment 381 
to women with reproductive failure a consensus on the quantification method and diagnostic 382 
criteria is essential. We hope that the findings in this study serve to highlight the importance 383 
of such a development. Whilst we have put forward data and argument to support that 384 
“plasma cell density” measurement is a more reliable method of plasma cell assessment for 385 
diagnosis of CE, ultimately, the proof of such a concept requires clinical studies to confirm 386 
that the measurement is of useful prognostic value and leads to effective treatment. 387 
To conclude, we have found that plasma cells may be present in small number in the 388 
endometrium of fertile subjects, the quantification of plasma cell density improves the 389 
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accuracy of the diagnosis of CE and the prevalence of CE in women with reproductive failure 390 
was only 10%, lower than previously reported. 391 
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Figure Legends 507 
Figure 1. Expression of plasma cells using (A) H&E staining, and (B) 508 
immunohistochemistry staining for syndecan-1(CD138) in the same field of endometrial 509 
tissue from the same woman. Plasma cells identified by black solid arrow. GE: glandular 510 
epithelium; SC: stromal cell; LE: luminal epithelium. Magnification: 400; Scale bar: 50 µm. 511 
Figure 2. Scatter plot of CD138+ cell count per unit area (cell density) in four subgroups of 512 
women (Fertile: fertile control women; RM: unexplained recurrent miscarriage; RIF: 513 
recurrent implantation failure; Infertility: infertile women undergoing endometrial scratch in 514 
a natural cycle preceding frozen-thawed embryo transfer). Reference range of CD138+ cell 515 
count per unit area is up to 5.15 CD138+ cells/0.1 mm
2
 showing on the Y axis. There was no 516 
statistically significant difference between subgroups by chi-square test.  517 
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Table 1 Prevalence of chronic endometritis reported in the literature among three groups of 518 
women (I) infertility, (II) recurrent miscarriage, and (III) recurrent implantation failure, in 519 
relation to inclusion criteria, diagnostic criteria and timing of endometrial biopsy.   520 
Note: HPF = high power field, 400 magnification. LH+6~8 = six to eight days after luteal hormonal surge.       521 
ET = embryo transfer. ESPDI = The endometrial stromal plasmacyte density index.522 
References Inclusion criteria 
Diagnostic criteria 
(plasma cell count) 
Timing of 
endometrial 
biopsy 
Prevalence 
(n/N) 
I. Infertility 
Cicinelli et al., 2005 Unexplained 
infertility 
≥1/section Follicular phase 30% 
(45/150) 
Kitaya and Yasuo, 
2010 
Unexplained 
infertility 
≥1/10 HPF LH+6~8 29%   
(22/76) 
Kasius et al., 2011 Infertility  ≥1/section Follicular phase 3%     
(17/606) 
Kitaya et al., 2012 Infertility ≥5/20 HPF Follicular phase  44%     
(23/52) 
II. Recurrent miscarriage, RM 
Kitaya, 2011 ≥3 miscarriages ≥1/10 HPF LH+6~8 9%        
(5/54) 
Zolghadri et al., 2011 ≥3 miscarriages  ≥1/section Follicular phase 43% 
(61/142) 
Cicinelli et al., 2014 ≥3 miscarriages ≥1/section  Follicular phase  53% 
(190/360) 
McQueen et al., 2015 ≥2 miscarriages  1-5/HPF or 
discrete clusters 
<20 
Not mentioned 56% 
(60/107) 
Bouet et al., 2016 ≥2 unexplained 
miscarriages  
≥5/10 HPF Follicular phase 27%     
(14/51) 
III. Recurrent implantation failure, RIF 
Johnston-
MacAnanny et al., 
2010 
≥2 failed ET cycles 
or >10 failed 
embryos transfer 
≥1/HPF Not mentioned 30%     
(10/33) 
Kitaya et al., 2017  ≥3 failed embryos 
transfer 
≥0.25 ESPDI Follicular phase 34%  
(142/421) 
Cicinelli et al., 2015 ≥3 failed ET cycles ≥1/section Follicular phase 57% 
(61/106) 
Bouet et al., 2016 ≥3 failed embryos 
transfer  
≥5/10 HPF Follicular phase 14%       
(6/43) 
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Table 2 The prevalence of chronic endometritis using three different quantification methods of CD138+ cell (I) CD138+ cell count per 10 523 
randomly chosen HPF; (II) CD138+ cell count per whole section; and (III) CD138+ cell count per unit area, in conjunction with selected 524 
diagnostic criteria.  525 
Population 
Methods used to quantify CD138+ cell 
(I) CD138+ cell count per 10 randomly 
chosen HPF 
(II) CD138+ cell count per whole section 
(III) CD138+ cell 
count per unit area  
P value
d
 (I-a) CE+ if 
≥1 
cell/10HPF 
(I-b) CE+ if 
≥1.95 
cells/10HPF 
P value
c
 
(II-a) CE+ if ≥
1 cell/section 
(II-b) CE+ if 
≥2.95 
cells/section 
P value
c
 
(III-b) CE+ if 
≥5.15 
cells/0.1mm
2
 
Fertile (n=40) 17.5% 5% 0.16 30.0% 5% <0.01 5% 
I-b vs II-b: 1.00 
I-b vs III-b: 1.00 
II-b vs III-b: 1.00 
Reproductive Failure  
(n=180)  
28.9% 18.9% 
0.02 
46.1% 22.2% 
<0.01 
10.0% 
I-b vs II-b: 0.26 
I-b vs III-b: 0.01 
II-b vs III-b: <0.01 P value
e
  0.10 0.02 <0.05 <0.01 0.49 
    RM (n=93) 19.4% 12.9% 
0.16 
38.7% 17.2% 
<0.01 
10.8% I-b vs II-b: 0.27 
I-b vs III-b: 0.41 
II-b vs III-b: 0.15     P value
e
 0.51 0.29 0.22 <0.05 0.46 
    RIF (n=39) 23.1% 15.4% 
0.28 
51.3% 20.5% 
<0.01 
7.7% I-b vs II-b: 0.38 
I-b vs II-b: 0.24 
II-b vs III-b: <1.00     P value
e
 0.37 0.25 <0.05 0.04 0.98 
    Infertility (n=48) 37.5% 29.2% 
0.26 
56.3% 33.3% 
0.02 
10.4% I-b vs II-b: 0.41 
I-b vs II-b: 0.02 
II-b vs III-b: <0.01 
    P value
e
 0.03 <0.01 0.01 <0.01 0.59 
Note: RM = recurrent miscarriage. RIF = recurrent implantation failure.  526 
Chi-Square test was used to compare the difference between subgroups. 527 
a, an arbitrary criteria used in literature.  528 
b, criteria based on reference range (95
th
 percentile) derived from fertile subjects.  529 
Three types of comparison are made: 530 
c
 using the same quantification method, the prevalence rate based on two different diagnostic criteria, a and b, are compared (I-a vs I-b; II-a vs II-b); and 531 
d
 using the same diagnostic criteria based on reference range derived from fertile subjects, i.e. b, the prevalence rate determined by three different quantification methods (I-b, 532 
II-b, III-b) are compared; and  533 
e
 using the same quantification method and diagnostic criteria, the prevalence rate between fertile subjects and women with reproductive failure and subgroups are compared.534 
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Supplementary Table 1 A comparison of demographics between different groups of 535 
subjects.  536 
 537 
Characteristics 
Fertile 
(n=40) 
RM      
(n=93) 
RIF     
(n=39) 
Infertility       
(n=48) 
Maternal age (y) 
a,c
 29.6 ± 3.4 35.0 ± 3.4 36.1 ± 2.7 35.7 ± 2.8 
BMI (kg/m
2
) 
a
 21.6 ± 2.0 22.1 ± 2.9 21.1 ± 2.4 21.7 ± 3.4 
Gravidity 
b
 2 (1 - 3) 3 (3 - 7) 0 (0 - 3) 1 (0 - 6) 
Parity 
b
 1 (1 - 3) 0 (0 - 1) 0 (0 - 1) 0 (0 - 2) 
Miscarriages 
b
 0 (0 - 1) 3 (3 - 6) 0 (0 - 1) 0 (0 - 2) 
Note: RM = Recurrent miscarriage. RIF = Recurrent implantation failure. BMI = Body mass index. 538 
ANOVA analysis was used to compare the difference between subgroups. 539 
a
 mean ± SD 540 
b
 median (range) 541 
c
 P<0.01: Fertile vs RM; Fertile vs RIF; Fertile vs Infertility.542 
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Supplementary Table 2 A comparison of the intra-observer variability (intraclass 543 
correlation coefficient, Observer A) among three quantification methods of CD138+ cell (I) 544 
CD138+ cell count per 10 randomly chosen HPF; (II) CD138+ cell count per whole section; 545 
(III) CD138+ cell count per unit area. 546 
Participant 
ID 
(I) CD138+ cell count per 
10 randomly chosen HPF 
(II) CD138+ cell count per 
whole section 
(III) CD138+ cell count per unit area 
1
st
 
Observation 
2
nd
 
Observation 
1
st
 
Observation 
2
nd
 
Observation 
Specimen area (mm
2
) 1st 
Observation 
2
nd
 
Observation 1
st
 
Observation 
2
nd
 
Observation 
1 0 0 0 0 9.789 11.297 0 0 
2 0 0 0 0 6.767 6.264 0 0 
3 0 0 0 0 4.763 4.705 0 0 
4 1 1 2 1 4.476 4.349 4.47 2.30 
5 0 0 0 0 5.057 4.887 0 0 
6 0 0 0 0 5.592 5.225 0 0 
7 0 1 1 1 4.943       4.655 2.02 2.15 
8 0 0 1 1 12.029 11.200 0.83 0.89 
9 1 1 2 1 13.673 14.225 1.46 0.70 
10 0 1 1 1 2.841 2.169 3.52 4.61 
11 1 0 2 2 10.249 9.874 1.95 2.03 
12 0 1 0 1 7.561 6.249 0 0 
13 0 0 0 0 8.078 6.500 0 0 
14 1 2 3 3 17.676 17.065 1.70 1.76 
15 0 0 0 0 12.620 9.675 0 0 
16 0 0 1 1 8.089 7.923 1.24 1.26 
17 0 0 0 0 3.225 3.178 0 0 
18 0 0 1 1 7.260 6.976 1.38 1.43 
19 0 0 0 0 2.067 2.268 0 0 
20 0 1 1 0 5.138 6.702 1.95 0 
Intra-CC 
(95% CI) 
0.46 
(0.06 to 0.74) 
0.90 
(0.76 to 0.96) 
0.97 
(0.92 to 0.99) 
0.84 
(0.64 to 0.93) 
Note: HPF = high power field,  400 magnification. Intra-CC = Intraclass Correlation Coefficient. 95% CI = 95% 547 
Confidence Interval.548 
549 
550 
551 
552 
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Supplementary Table 3 A comparison of the inter-observer variability (intraclass 553 
correlation coefficient, Observer A and B) among three quantification methods of CD138+ 554 
cell (I) CD138+ cell count per 10 randomly chosen HPF; (II) CD138+ cell count per whole 555 
section; (III) CD138+ cell count per unit area. 556 
Participant 
ID 
(I) CD138+ cell count per 10 
randomly chosen HPF 
(II) CD138+ cell count 
per whole section 
(III) CD138+ cell count per unit area  
Observer A Observer B Observer A Observer B 
Specimen area (mm
2
) 
Observer A Observer B 
Observer A Observer B 
1 0 0 0 0 9.789 12.184 0 0 
2 0 0 0 0 6.767 6.771 0 0 
3 0 0 0 0 4.763 4.737 0 0 
4 1 1 2 2 4.476 5.793 4.47 3.45 
5 0 0 0 0 5.057 4.890 0 0 
6 0 0 0 0 5.592 6.071 0 0 
7 0 1 1 1 4.943 5.173 2.02 1.93 
8 0 0 1 1 12.029 11.803 0.83 0.85 
9 1 0 2 1 13.673 11.727 1.46 0.85 
10 0 1 1 1 2.841 2.923 3.52 3.42 
11 1 0 2 2 10.249 9.248 1.95 2.16 
12 0 1 0 1 7.561 5.487 0 1.82 
13 0 0 0 0 8.078 8.552 0 0 
14 1 2 3 3 17.676 18.555 1.70 1.62 
15 0 0 0 0 12.620 10.188 0 0 
16 0 0 1 1 8.089 6.859 1.24 1.46 
17 0 0 0 0 3.225 3.293 0 0 
18 0 0 1 0 7.260 6.328 1.38 0 
19 0 0 0 0 2.067 2.011 0 0 
20 0 0 1 0 5.138 5.077 1.95 0 
Intra-CC 
(95% CI) 
0.39 
(-0.06 to 0.70) 
0.88 
(0.72 to 0.95) 
0.96 
(0.90 to 0.98) 
0.83 
(0.62 to 0.93) 
Note: HPF = high power field, 400 magnification; Intra-CC = Intraclass Correlation Coefficient. 95% CI = 95% 557 
Confidence Interval. 558 
